NEW YORK (GenomeWeb News) – PerkinElmer said today it will buy Pediatrix Medical’s newborn metabolic screening business, which includes a laboratory and StepOne product, for an undisclosed amount.
 
Pediatrix’s StepOne screening product can analyze over 50 inherited disorders in newborns, PerkinElmer said. The screening lab offers its services to hospitals, medical groups, and to the states of Maryland, Mississippi, Louisiana, Nebraska and Pennsylvania, as well as the District of Columbia.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.